William Blair Starts aTyr Pharma (LIFE) at Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/31/2026

1. AMZN
2. RBLX
3. AAPL
4. COIN
5. RDDT
6. NBIX
7. DXCM
8. FND
9. GH
10. GDDY

Go back to William Blair Starts aTyr Pharma (LIFE) at Outperform

Citi Starts aTyr Pharma (LIFE) at Buy

June 1, 2015 8:04 AM EDT

Citi initiated coverage on aTyr Pharma (NASDAQ: LIFE) with a Buy rating and a price target of $32.00.

For an analyst ratings summary and ratings history on aTyr Pharma click here. For more ratings news on aTyr Pharma click here.

Shares of aTyr Pharma closed at $22.89 yesterday.

... More

JPMorgan Starts aTyr Pharma (LIFE) at Overweight

June 1, 2015 6:57 AM EDT

JPMorgan initiated coverage on aTyr Pharma (NASDAQ: LIFE) with an Overweight rating and a price target of $42.00.

For an analyst ratings summary and ratings history on Life Technologies click here. For more ratings news on Life Technologies click here.

Shares of Life Technologies closed at $22.89 yesterday.

... More

UPDATE: BMO Capital Starts aTyr Pharma (LIFE) at Outperform

June 1, 2015 6:34 AM EDT

(Updated - June 1, 2015 7:03 AM EDT)

BMO Capital initiates coverage on aTyr Pharma (NASDAQ: LIFE) with a Outperform rating and a price target of $42.00.

Analyst Jim Birchenough commented, "Our favorable rating and outlook is supported by the company's identification of, and proprietary dominance in, the area of Physiocrine... More